ICD-10 code L00: Staphylococcal scalded skin syndrome

ICD-10 code L00 is the billable diagnosis code for staphylococcal scalded skin syndrome. It covers an exfoliative skin disorder caused by toxin-producing Staphylococcus aureus, which predominantly affects neonates and young children.

Coders frequently confuse L00 with toxic epidermal necrolysis (L51.2), because both conditions cause widespread skin separation. The two are mutually exclusive under an Excludes1 note, so they can never be coded together. Missing the mandatory additional organism code, or assigning L51.2 instead of L00, are the two most common reasons claims for this condition are denied.

Found our content helpful?

Key takeaways

L00 covers staphylococcal scalded skin syndrome, with Ritter disease as its one included term.

Pemphigus neonatorum is excluded from L00 under an Excludes1 note and codes to L01.03, bullous impetigo.

An additional B95 code (B95.61 for MSSA or B95.62 for MRSA) is mandatory alongside L00 per the tabular instructional note.

Toxic epidermal necrolysis (L51.2) is excluded from L00 via an Excludes1 note and can never be coded together with it.

Pabau’s claims management software flags missing organism codes before submission, reducing L00-related claim denials.

ICD-10 code L00: Official description and code structure

ICD-10 code L00 is the official ICD-10-CM code for staphylococcal scalded skin syndrome. It sits within Chapter 12 (Diseases of the skin and subcutaneous tissue, L00-L99). Within that chapter it belongs to the L00-L08 block, which covers infections of the skin and subcutaneous tissue. According to the CDC/NCHS ICD-10-CM web tool, L00 carries full billable status and can be used on both inpatient and outpatient claims.

L00 has no subcategory codes. The code is complete as written, and no 4th or 5th character extension is required. For the most current lookup, coders should verify against the official CMS annual tabular release and any mid-year addenda.

Clinical overview: What is staphylococcal scalded skin syndrome?

Staphylococcal scalded skin syndrome is a toxin-mediated exfoliative skin disorder. It is caused by exfoliative toxins (ET-A and ET-B) produced by certain strains of Staphylococcus aureus. The toxins cleave desmoglein-1, the protein that holds the upper layers of the skin together. Sheets of superficial epidermis then separate without the deeper dermis being involved, which is the key clinical distinction from toxic epidermal necrolysis.

The condition predominantly affects neonates, infants, and children under five years of age. Adult presentations occur but are rare, almost exclusively in patients with renal impairment (which reduces toxin clearance) or immunosuppression. Knowing the patient population matters for coding accuracy. Documentation of age and immune status directly supports medical necessity for the assigned diagnosis.

• Causative organism: Staphylococcus aureus (MSSA or MRSA strains capable of exfoliative toxin production)
• Primary patient population: Neonates and children under five; rarely adults with renal failure or immunosuppression
• Mechanism: Exfoliative toxins ET-A and ET-B cleave desmoglein-1 in the granular layer of the epidermis
• Clinical presentation: Generalized erythema, flaccid bullae, positive Nikolsky sign, superficial skin peeling with large denuded areas
• Systemic source: The staph infection may be remote (for example, umbilical or nasopharyngeal) rather than at the site of skin involvement

For coding purposes, the critical clinical fact is that skin detachment in SSSS is superficial and spares the dermis. That is both the physiological basis of L00 and the key differentiator from L51.2 when reviewing the clinical note. Accurate documentation of this distinction by the treating physician is what allows the coder to assign L00 confidently.

Ritter disease is included under L00, pemphigus neonatorum is not

Ritter disease is the same condition as staphylococcal scalded skin syndrome. The name refers to the neonatal presentation, first described by Gottfried Ritter von Rittershain. The ICD-10-CM Tabular List carries it as the one included term under L00, so no separate code exists for it.

Pemphigus neonatorum is handled differently, and this is where coders most often go wrong. It appears under the Excludes1 note at L00, not among the included terms. A note documenting pemphigus neonatorum codes to L01.03, bullous impetigo, and never to L00.

A coder who searches for “Ritter disease” in an encoder should be routed to L00. If the encoder returns no result or a different code, verify against the official WHO ICD-10 browser. The included-term relationship means a note documenting “Ritter disease of the newborn” is coded exactly like one documenting “staphylococcal scalded skin syndrome”. No query to the physician is needed for that wording alone.

What L00 includes and excludes: Instructional notes decoded

The ICD-10-CM Tabular List places two sets of instructional notes at the L00 code entry that coders must apply before assigning the code. Missing either note is the root cause of most L00 claim denials.

Use additional code note

L00 carries a “Use additional code” instruction to identify the infectious agent. This note is mandatory, not optional. The organism code is selected from the B95-B97 range. For the most common SSSS scenario:

• B95.61: Methicillin-susceptible Staphylococcus aureus (MSSA) as the cause of diseases classified elsewhere
• B95.62: Methicillin-resistant Staphylococcus aureus (MRSA) as the cause of diseases classified elsewhere
• B95.7: Other staphylococcus as the cause of diseases classified elsewhere (a named staphylococcal species other than S. aureus)
• B95.8: Unspecified staphylococcus as the cause of diseases classified elsewhere (when the species or susceptibility has not been confirmed)

Verify the exact B95 codes against the current CMS tabular before assigning. The MSSA and MRSA codes (B95.61, B95.62) are well established. Susceptibility status still has to be confirmed by culture results documented in the clinical note before you select between them.

Excludes1 note

Toxic epidermal necrolysis (L51.2) appears under an Excludes1 note at L00, alongside pemphigus neonatorum. An Excludes1 note means the excluded code can never be used at the same time as L00 on the same claim. If the clinical note documents TEN, code L51.2, not L00. Assigning both on the same encounter is a coding error regardless of payer.

Key differential: L00 vs toxic epidermal necrolysis (L51.2) vs impetigo (L01)

Three conditions cause most of the confusion for coders working with exfoliative and blistering skin disorders. The panel below shows which findings in the note route to which code, and the full comparison follows it.

The practical differentiator between L00 and L51.2 during chart review is mucous membrane involvement and drug history. TEN involves the mouth, eyes, and genitals, while SSSS does not. If the physician’s note documents mucosal erosions, the code is L51.2. Cross-referencing guidance for these exclusion relationships is available through the AAPC Codify ICD-10-CM lookup.

Additional code requirement: Identifying the infectious agent

The “Use additional code” instruction under L00 is a sequencing rule, not a reminder. Submitting L00 without the corresponding B95 organism code will cause the claim to fail medical necessity review at payers that audit ICD-10-CM instructional compliance.

How to select the correct B95 code

1. Review culture results: The clinical note or lab report must document a positive S. aureus culture and its susceptibility pattern before you select between MSSA and MRSA codes.
2. MSSA confirmed: Assign B95.61 (Methicillin-susceptible Staphylococcus aureus as the cause of diseases classified elsewhere) as the secondary code after L00.
3. MRSA confirmed: Assign B95.62 (Methicillin-resistant Staphylococcus aureus as the cause of diseases classified elsewhere).
4. Susceptibility not documented: Assign B95.8 (Unspecified staphylococcus as the cause of diseases classified elsewhere) and query the provider for susceptibility data if available.
5. Sequence correctly: L00 is the principal/first-listed diagnosis. The B95.xx code follows as an additional code – never reverse this order.

The organism code matters beyond compliance. It affects clinical documentation completeness, infection control reporting, and, in inpatient settings, potential CC/MCC status for DRG assignment. A practice running software that validates claims can flag missing secondary codes on skin infection diagnoses before submission. That stops the denial at its source.

Documentation requirements for L00: What coders need from the clinical note

A clinical note that supports L00 must give the coder enough specificity to confirm both the diagnosis and the organism. Most L00 denials trace back to a note that stopped short of one of those two, rather than to the code selection itself.

Following medical billing compliance requirements, the documentation checklist for L00 includes:

• Physician-confirmed diagnosis: The attending or treating physician must document “staphylococcal scalded skin syndrome,” “SSSS,” or “Ritter disease.” Coders may not infer the diagnosis from clinical signs alone, and a note reading “pemphigus neonatorum” routes to L01.03 instead.
• Age and patient context: Documentation of the patient’s age (especially for neonates) and any immunosuppression or renal impairment supports medical necessity for adult presentations.
• Culture results or organism identification: Lab documentation confirming S. aureus and susceptibility pattern is required to select the correct B95 secondary code. If culture results are pending, use B95.8 and update when confirmed.
• Extent of skin involvement: The note should describe the distribution and severity of skin separation, which supports inpatient admission justification and DRG assignment when applicable.
• Source of infection: SSSS toxins are produced at a remote infection site, such as the umbilical stump or nasopharynx. Noting that primary site helps justify the clinical picture and rule out TEN.
• Absence of mucous membrane involvement: Documenting that mucosal surfaces are uninvolved directly distinguishes SSSS from TEN and prevents an Excludes1 coding error.

If any of these elements are absent, the coder should query the physician before assigning L00. Assumptions about organism identity or diagnosis name are not permitted under ICD-10-CM official guidelines.

Common claim denial reasons for L00 and how to prevent them

Denials on L00 claims fall into four consistent patterns. Each has a defined corrective action that can be built into the pre-submission workflow.

Building a claim edit that requires a B95 code whenever L00 is present removes the most common failure point. Tracking which preventable denial codes keep returning shows whether the fault sits in the code pair, the sequencing, or the clinical note. Practice management software like Pabau applies those edits while the note is written, so the pair is complete before the claim file is built.

Payer and reimbursement considerations for staphylococcal scalded skin syndrome

SSSS requires inpatient admission in most pediatric presentations, because of the extent of skin involvement, fluid management needs, and IV antibiotic requirements. Inpatient claims with L00 as the principal diagnosis group to DRG 595 or 596 in the CMS MS-DRG grouper. Those are major skin disorders with and without MCC. Which of the two applies depends on whether documented complications or comorbidities meet CC/MCC criteria, so verify against the current IPPS final rule.

• Inpatient setting: L00 groups into the major skin disorders DRG family. MRSA documentation (B95.62) may qualify as a CC, depending on the CMS CC/MCC designation tables for the current fiscal year.
• Outpatient setting: Mild SSSS presentations in older children may be managed outpatient. CMS does not mandate inpatient admission for L00, so the setting is determined by clinical judgment and documented in the record.
• Commercial payers: Prior authorization is not typically required for SSSS, given its acute and emergent nature. Confirm individual payer policies anyway, particularly for extended inpatient stays.
• Medicare: Adult SSSS presentations are uncommon and almost always involve documented renal impairment or immunosuppression. Code those comorbidities as secondary diagnoses to support medical necessity for inpatient admission.

Electronic remittance advice carries the denial reason in coded form, which lets revenue cycle staff triage L00 rejections quickly. CARC codes on the remittance identify whether the rejection was a medical necessity issue, a coding edit failure, or a coverage exclusion. That narrows the correction without a call to the payer.

ICD-10-CM 2026 updates: Is L00 valid for the current fiscal year?

L00 is valid for FY2026 ICD-10-CM coding. The code descriptor, instructional notes, and included terms are unchanged in the most recent tabular release reviewed at publication. The code has remained stable across multiple fiscal years without revision. Coders should still verify currency against the official CMS release, as mid-year addenda occasionally affect adjacent L-chapter codes.

For ongoing FY2026 verification, bookmark the CMS ICD-10 codes page. It publishes both the annual tabular release and any addenda effective April 1 and October 1. Tabular changes often ripple across related codes in the L00-L08 block, so check the neighboring codes when L00 itself comes back unchanged.

How Pabau supports accurate ICD-10 coding and dermatology documentation

Accurate L00 coding depends on three steps holding every time. The physician has to document the right diagnostic language. The coder then captures the mandatory B95 secondary code. Finally the claim clears without a code-edit rejection. Pabau’s practice management and EHR platform supports all three for dermatology and skin practice workflows.

• Structured clinical documentation: Configurable note templates prompt providers for organism confirmation and skin involvement extent. Those two elements are the ones most often missing from denied L00 claims.
• Built-in ICD-10 catalogs: The platform includes searchable ICD-10-CM code sets. Coders look up L00, check its included term, and confirm the B95 pairing without leaving the workflow.
• Claim submission via the Claim.MD clearinghouse: The integration validates ICD-10 code completeness and payer-specific edits before the 837P file transmits. Missing organism codes on L00 claims get caught there.
• Denial tracking: ERA posting through the Claim.MD connection surfaces CARC denial codes on L00 rejections in the practice dashboard. Root-cause analysis becomes systematic rather than manual.

Skin practices handle a mix of dermatology coding across the L00-L99 chapter. One workflow keeps the clinical note and the submitted claim in step. The coder works from the note the physician wrote, and the edits run before the claim file leaves the practice.

Catch missing organism codes before claims go out

Pabau’s built-in ICD-10 and CPT code catalogs flag incomplete code pairs as the note is written. An L00 claim never ships without its required B95 secondary code.

Book a demo

Conclusion

L00 is a straightforward billable code that still generates repeat denials, and the cause is rarely the diagnosis. Three failures account for most of them. The mandatory B95 organism code is omitted. TEN (L51.2) is coded in its place. A note reading “pemphigus neonatorum” goes to L00 instead of L01.03.

Two changes fix all three. Build a claim edit that requires a B95 secondary code whenever L00 is assigned. Then train documentation staff on the SSSS versus TEN differentiators, so the physician note supports the correct code from the start. Practices that make those changes stop reworking the same claim twice.

Pabau’s claims management tools and Claim.MD integration give dermatology and pediatric practices a code-validation layer. It catches an incomplete pair before the claim is sent. Book a demo to see how Pabau handles skin infection coding from the clinical note through to the remittance.

Continue your research

Need a full claims management walkthrough? Claims management software explains how Pabau’s built-in code validation and Claim.MD integration reduce skin infection billing errors.

Managing denial patterns across your practice? Denial management in healthcare covers root-cause analysis frameworks for reducing repeat denials on ICD-10 code categories.

Want to understand the clearinghouse connection? Claim.MD clearinghouse overview details how electronic claim validation works before the 837P file transmits to payers.

Frequently asked questions